Quach M Edward, Li Renhao
Aflac Cancer and Blood Disorders Center, Department of Pediatrics, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA, USA.
J Thromb Haemost. 2020 Dec;18(12):3131-3141. doi: 10.1111/jth.15035. Epub 2020 Aug 24.
The glycoprotein (GP)Ib-IX receptor complex plays a critical role in platelet physiology and pathology. Its interaction with von Willebrand factor (VWF) on the subendothelial matrix instigates platelet arrest at the site of vascular injury and is vital to primary hemostasis. Its reception to other ligands and counter-receptors in the bloodstream also contribute to various processes of platelet biology that are still being discovered. While its basic composition and its link to congenital bleeding disorders were well documented and firmly established more than 25 years ago, recent years have witnessed critical advances in the organization, dynamics, activation, regulation, and functions of the GPIb-IX complex. This review summarizes important findings and identifies questions that remain about this unique platelet mechanoreceptor complex.
糖蛋白(GP)Ib-IX受体复合物在血小板生理和病理过程中起着关键作用。它与内皮下基质上的血管性血友病因子(VWF)相互作用,促使血小板在血管损伤部位黏附,这对初级止血至关重要。它与血液中其他配体和反受体的相互作用也有助于血小板生物学的各种仍在被发现的过程。虽然其基本组成及其与先天性出血性疾病的联系在25多年前就有充分记录并得到牢固确立,但近年来,GPIb-IX复合物在组织、动力学、激活、调节和功能方面取得了关键进展。本综述总结了重要发现,并确定了关于这种独特的血小板机械感受器复合物仍存在的问题。